Direct oral anticoagulants in children with giant coronary artery aneurysms from Kawasaki disease: a systematic review and meta-analysis
Direkte orale Antikoagulanzien bei Kindern mit riesigen Koronararterienaneurysmen bei Kawasaki-Krankheit: systematische Übersicht und Metaanalyse
Frontiers in Cardiovascular Medicine · 10.04.2026 · 13
DOI: 10.3389/fcvm.2026.1777856 ↗Auf einen Blick
Fünf Studien mit 594 Patient:innen verglichen DOACs mit Standardtherapie bei KD-assoziierten GCAAs. Für thromboembolische Ereignisse zeigte sich kein statistisch signifikanter Unterschied.
Fragestellung
Wie wirksam und sicher sind DOACs im Vergleich zur konventionellen Antikoagulation bei Kindern mit KD-assoziierten GCAAs?
Methode
Systematische Übersicht und Metaanalyse; Suche in PubMed, Embase, Cochrane Central und ClinicalTrials.gov bis Oktober 2025; random-effects Modell.
Ergebnisse
5 Studien mit 594 Patient:innen. Thromboembolische Ereignisse: RR 0,27 (95 %-KI 0,02–3,17; p=0,29). In 2 RCTs: RR 0,26 (95 %-KI 0,05–1,49; p=0,13).
Schlussfolgerung der Autor:innen
DOACs haben potenziell nicht unterlegene Wirksamkeits- und Sicherheitsprofile im Vergleich zu konventionellen Wirkstoffen und unterstützen ihren Einsatz als First-line-Antikoagulation.
Kernaussagen
- 5 Studien mit 594 Patient:innen
- Kein statistisch signifikanter Unterschied bei thromboembolischen Ereignissen
- Major- oder CRNM-Blutungen ähnlich häufig
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 10.04.2026. Verfasst von Sze Kiat Alan Ong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore, Singapore. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Background
To evaluate the comparative efficacy and safety profile of direct oral anticoagulants (DOACs) vs. conventional anticoagulation in children with Kawasaki disease (KD)-associated Giant coronary artery aneurysms (GCAAs).
Methods
Databases searched included PubMed (MEDLINE), Embase, Cochrane Central Register of Controlled Trials and ClinicalTrials.gov from conception until October 2025. Studies that (1) enrolled patients younger than 19 years with documented KD-associated GCAAs; (2) administered DOACs; (3) reported at least one efficacy/safety outcome, were included. Efficacy outcomes included thromboembolic events (coronary thrombosis, myocardial infarction, systemic thromboembolism). Safety outcomes included major or Clinically Relevant Non-Major (CRNM) bleeding. A random-effects model was used to estimate the pooled effects.
Results
Five studies [two randomized clinical trials (RCTs), two observational studies and one prospective interventional trial] were included with a total of 594 patients [DOACs: 474 (79.8%); standard of care, SOC: 120 (20.2%)]. The overall risk ratio of thromboembolic events for patients on DOACs vs. SOC was not statistically significant [RR 0.27 (95% CI: 0.02–3.17); p = 0.29]. The estimated pooled major or CRNM bleeding event rate was similar [DOACs: Proportion 0.001 (95% CI: 0.00–0.01)] vs. SOC: Proportion 0.03 (95% CI: 0.01–0.07). In the two RCTs, the estimated risk ratio between DOACs vs. SOC was not statistically significant [RR 0.26 (95% CI: 0.05–1.49); p = 0.13].
Conclusion
DOACs have potentially non-inferior efficacy and safety profiles compared to conventional agents, supporting the use of DOACs as a first-line anticoagulation strategy in one of childhood's most serious cardiovascular conditions. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251004094 , PROSPERO CRD420251004094.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Paediatrics, Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore, Singapore.
- Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Biostatistics Unit, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
- Department of Cardiology, National University Heart Center, Singapore, Singapore.
Zitieren
APA
Ong, S. K. A., Raj, D., Lee, A. W. X., Shen, L., Poh, K. K., Koh, P. L., & Quek, S. C. (2026). Direct oral anticoagulants in children with giant coronary artery aneurysms from Kawasaki disease: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1777856
Vancouver
Ong SKA, Raj D, Lee AWX, Shen L, Poh KK, Koh PL, et al. Direct oral anticoagulants in children with giant coronary artery aneurysms from Kawasaki disease: a systematic review and meta-analysis. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1777856
BibTeX
@article{Ong2026,
author = {Ong, Sze Kiat Alan and Raj, Deepan and Lee, Anika W Xuen and Shen, Liang and Poh, Kian Keong and Koh, Pei Lin and Quek, Swee Chye},
title = {Direct oral anticoagulants in children with giant coronary artery aneurysms from Kawasaki disease: a systematic review and meta-analysis},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1777856}
}
EUVIMED